Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Breast imaging is a subspecialty of diagnostic radiology which involves a range of imaging procedure to obtain a high resolution visualization of breast tissues and associated diseases. Breast cancer is the most common cancer found in women. Breast imaging techniques play a vital role in early diagnosis of the disease, evaluating the progress of the disease. The early detection of breast cancer can help patient and physician to decide suitable treatment and it also enables doctors to monitor the efficacy of treatment and how patients would respond to it. The current practice of screening is based on mammography, ultrasound, MRI, nuclear imaging and thermography. A screening mammogram can identify the presence of cancer, often before symptoms arise. The American Medical Association (AMA) and the American College of Radiology (ACR) recommend annual mammograms for women over 40.
This market is expected to witness significant growth during the forecast period owing to increase in incidence of breast cancer worldwide, supportive government initiatives to increase proactive initiatives by healthcare organizations to raise awareness about early breast cancer detection.
Breast cancer is the most frequent cancer among women. As per World Health Organisation Data, breast cancer is impacting 2.1 million women each year. In 2018, it is estimated that 627,000 women died from breast cancer. The breast cancer mortality rate is approximately 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally.
In addition, launch of technological advanced modalities such as automated whole breast ultrasound system (AWBU) and MBI/BSGI) fuel the market growth. However, high cost of breast imaging technologies and stringent regulatory approval processes are expected to challenge the breast imaging technologies market growth.
The global breast imaging technologies market is segmented by product type and geography.
Based on product, the market is segmented into Ionizing Breast Imaging Technologies and Non-ionising Breast Imaging Technology. The Ionising Breast Imaging Technologies is further segmented into Mammography, Positron Emission Tomography-Computed Tomography (Pet-Ct), Molecular Breast Imaging, Positron Emission Mammography. The Mammography segment is further sub classified into Full-Field Digital Mammography, Analog Mammography and 3D Breast Tomosynthesis. The non-ionising technologies include Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography and Other Breast Imaging Technologies (Optical Imaging, Cone-Beam Computed Tomography, and Electric Impedance Tomography). The Ionizing breast imaging modalities are widely adopted for the screening of breast cancer owing to the technological advancement this type of technologies and growing awareness about the early screening and diagnosis of breast cancer. Mammography is the most generally utilized screening instrument for diagnosis and screening tool for breast cancer. It helps to detect breast cancer at an early stage, being the most critical instrument in breast cancer diagnosis for women at 40 years old or more.
The breast imaging market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.
North America dominated the global Breast Imaging Technologies market in 2018. The large share of the market is attributed to the factors such as the rising incidence of breast cancer coupled with the easy accessibility and high adoption of advanced diagnostic technologies, significant per capita annual healthcare expenditure in the US and Canada, and the rapidly increasing geriatric population in the region.
However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. A number of factors, such as the growing patient populace, improving healthcare infrastructure, rising government spending on breast cancer research studies, growing healthcare expenditure and implementation of several initiatives to create awareness about the early detection of breast cancer are expected to drive the market in the Asia-Pacific region during the forecast period.
January, 2019: Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, in order to further expand its Healthcare Business in North America has acquired Core Medical Imaging Inc. (CMI) with its head office in Kenmore
December, 2018: GE Healthcare launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This device is the only U.S. Food and Drug Administration (FDA)-approved ultrasound supplemental breast screening technology, according to GE, specifically designed for detecting cancer in dense breast tissue. When used in addition to mammography, Invenia ABUS can improve breast cancer detection by 55 percent over mammography alone.
March, 2018: Philips and Hologic announce global partnership agreement to provide integrated imaging solutions for women’s health. This Partnership will allow hospitals easier access to integrated suites of diagnostic imaging modalities, advanced informatics and services for comprehensive breast screening and diagnosis
The major players in Breast Imaging Technologies includes Hologic, Inc., GE Healthcare, Siemens Healthineers, HOLOGIC, INC., Philips Healthcare, Aurora Imaging Technology, Inc., FUJIFILM Holdings Corporation, Toshiba Corporation, Canon Inc., CMR Naviscan Corporation , Delphinus Medical Technologies, Inc., Inc. , Micrima Limited, Planmed Oy, SonoCiné, Inc and SuperSonic Imagine among others
Breast Imaging Technologies is used to obtain high resolution visualization of breast tissues and associated diseases. Breast cancer is a major disease cause of the breast disease that require immediate screening, which in turn is anticipate to boost growth of the breast imaging market.
The global Breast Imaging Technologies market is segmented on the basis of type, application, end user and region.
The market by product type is segmented into Ionizing Breast Imaging Technologies and Non-ionising Breast Imaging Technology. The Ionising Breast Imaging Technology is further segmented into Mammography, Positron Emission Tomography-Computed Tomography (Pet-Ct), Molecular Breast Imaging, Positron Emission Mammography. The Mammography segments is further sub classified into Full-Field Digital Mammography, Analog Mammography and 3D Breast Tomosynthesis. The non-ionising technologies includes Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography and Other Breast Imaging Technologies (Optical Imaging, Cone-Beam Computed Tomography, and Electric Impedance Tomography).
Geographically, the market is analysed across regions, such as North America, Europe, Asia-Pacific, and Rest of the World. Asia Pacific is anticipated to witness the fastest growth over the forecast period. Supportive government policies to improve healthcare system coupled with the economic developments are anticipated to be governing factors for growth.
Why to buy this report:
